CRMD FY 2020 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$239,231-15.5% YoY

Gross Profit

$34,38514.4% margin

Operating Income

-$27M-11378.4% margin

Net Income

-$22M-9207.7% margin

EPS (Diluted)

$-0.77

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$49M

Total Liabilities

$5M

Stockholders' Equity

$44M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$239,231	$283,266	-15.5%
Gross Profit	$34,385	-$89,968	+138.2%
Operating Income	-$27M	-$21M	-29.6%
Net Income	-$22M	-$16M	-34.0%